Effect of Tiladi Churna (orally) with Vidangadi Lepa in the Management of Dadru Kushtha(Fungal Infection)
Phase 2
- Conditions
- Health Condition 1: B359- Dermatophytosis, unspecified
- Registration Number
- CTRI/2024/03/064687
- Lead Sponsor
- All India Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with classical sign and symptoms of Dadru Kushtha
Patients willing to participate.
Exclusion Criteria
Patients suffering from Systemic Disorders, uncontrolled DM, HIV, Hepatitis- B, malignancy.
Cases of Burn.
Known cases of any other skin disease.
Any allergic condition related to skin and hypersensitivity to any medicine.
Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Resolution in the sign and symptoms of Dadru kushthaTimepoint: Assessment of sign and symptoms of dadru kushtha at baseline,30th day,60th day
- Secondary Outcome Measures
Name Time Method •To observe & determine the growth of fungus in Dadru kushtha by culture study. <br/ ><br>•To observe the Antifungal effect of Vidangadi lepa through sensitivity <br/ ><br>Timepoint: 1.Identification of fungus by microscopic examination using KOH(potassium hydroxide)10% at baseline <br/ ><br>2.Assessment of Antifungal effect of Vidangadi lepa through sensitivity at baseline <br/ ><br>